CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits
1.3.Key market segments
1.4.Research methodology

1.4.1.Primary research
1.4.2.Secondary Research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.key findings of the study:
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top impacting factors
3.2.2.Top investment pockets
3.2.3.Top winning strategies, 2016-2018

3.3.Porter's five forces analysis

3.3.1.Moderate bargaining power of buyers
3.3.2.Low bargaining power of suppliers
3.3.3.Moderate threat of substitutes
3.3.4.Low threat of new entrants
3.3.5.Moderate competitive rivalry

3.4.Value chain analysis
3.5.Government regulations

3.5.1.COPD devices regulations in Europe and in the U.S.
3.5.2.COPD devices regulations in Asia-Pacific

3.6.Clinical trials
3.7.Patent analysis

3.7.1.Patent analysis by region
3.7.2.U.S. Patent analysis
3.7.3.Europe patent analysis
3.7.4.Japan patent analysis

3.8.Drivers

3.8.1.Daily exposure to environmental pollution
3.8.2.Increase in population susceptible to indoor air pollutants
3.8.3.Portability of the drug delivery devices
3.8.4.Increasing population of active smokers
3.8.5.Rising government initiatives

3.9.Restraints

3.9.1.Increase in price competition and deterioration of material quality
3.9.2.Overall high cost of asthma treatment is a challenge for the patients
3.9.3.Incompetent reimbursement support

3.10.Opportunities

3.10.1.Patent expiration for blockbuster drugs
3.10.2.Smart Inhaler: future growth driver

CHAPTER 4:COPD AND ASTHMA DEVICES MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Inhalers

4.2.1.Market size and forecast
4.2.2.Market share analysis, by country
4.2.3.Drug powdered inhalers (DPIs)

4.2.3.1.Key market trends and opportunity

4.2.4.Metered dose inhalers (MDIs)

4.2.4.1.Key market trends and opportunity

4.2.5.Soft mist inhalers

4.2.5.1.Key market trends and opportunity

4.3.Nebulizers

4.3.1.Market size and forecast
4.3.2.Market share analysis, by country

4.3.2.1.Compressor nebulizers
4.3.2.2.Ultrasonic nebulizers
4.3.2.3.Mesh nebulizers

CHAPTER 5:COPD AND ASTHMA DEVICES MARKET, BY INDICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Asthma

5.2.1.Market size and forecast
5.2.2.Market share analysis, by country

5.3.COPD

5.3.1.Market size and forecast
5.3.2.Market share analysis, by country

CHAPTER 6:COPD AND ASTHMA DEVICES MARKET, BY DISTRIBUTION CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Retail Pharmacies

6.2.1.Market size and forecast
6.2.2.Market share analysis, by country

6.3.Hospitals

6.3.1.Market size and forecast
6.3.2.Market share analysis, by country

6.4.Online Pharmacies

6.4.1.Market size and forecast
6.4.2.Market share analysis, by country

CHAPTER 7:COPD & ASTHMA DEVICE MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends and opportunities
7.2.2.North America market size and forecast, by country
7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by indication
7.2.5.North America market size and forecast, by distribution channel

7.2.5.1.U.S.

7.2.5.1.1.U.S. market size and forecast, by product
7.2.5.1.2.U.S. market size and forecast, by indication
7.2.5.1.3.U.S. market size and forecast, by distribution channel

7.2.5.2.Canada

7.2.5.2.1.Canada market size and forecast, by product
7.2.5.2.2.Canada market size and forecast, by indication
7.2.5.2.3.Canada market size and forecast, by distribution channel

7.2.5.3.Mexico

7.2.5.3.1.Mexico market size and forecast, by product
7.2.5.3.2.Mexico market size and forecast, by indication
7.2.5.3.3.Mexico market size and forecast, by distribution channel

7.3.Europe

7.3.1.Key market trends and opportunities
7.3.2.Europe market size and forecast, by country
7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by indication
7.3.5.Europe market size and forecast, by distribution channel

7.3.5.1.Germany

7.3.5.1.1.Germany market size and forecast, by product
7.3.5.1.2.Germany market size and forecast, by indication
7.3.5.1.3.Germany market size and forecast, by distribution channel

7.3.5.2.UK

7.3.5.2.1.UK market size and forecast, by product
7.3.5.2.2.UK market size and forecast, by indication
7.3.5.2.3.UK market size and forecast, by distribution channel

7.3.5.3.France

7.3.5.3.1.France market size and forecast, by product
7.3.5.3.2.France market size and forecast, by indication
7.3.5.3.3.France market size and forecast, by distribution channel

7.3.5.4.Italy

7.3.5.4.1.Italy market size and forecast, by product
7.3.5.4.2.Italy market size and forecast, by indication
7.3.5.4.3.Italy market size and forecast, by distribution channel

7.3.5.5.Russia

7.3.5.5.1.Russia market size and forecast, by product
7.3.5.5.2.Russia market size and forecast, by indication
7.3.5.5.3.Russia market size and forecast, by distribution channel

7.3.5.6.Rest of Europe

7.3.5.6.1.Rest of Europe market size and forecast, by product
7.3.5.6.2.Rest of Europe market size and forecast, by indication
7.3.5.6.3.Rest of Europe market size and forecast, by distribution channel

7.4.Asia-Pacific

7.4.1.Key market trends and opportunities
7.4.2.Asia-Pacific market size and forecast, by country
7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by indication
7.4.5.Asia-Pacific market size and forecast, by distribution channel

7.4.5.1.Japan

7.4.5.1.1.Japan market size and forecast, by product
7.4.5.1.2.Japan market size and forecast, by indication
7.4.5.1.3.Japan market size and forecast, by distribution channel

7.4.5.2.China

7.4.5.2.1.China market size and forecast, by product
7.4.5.2.2.China market size and forecast, by indication
7.4.5.2.3.China market size and forecast, by distribution channel

7.4.5.3.India

7.4.5.3.1.India market size and forecast, by product
7.4.5.3.2.India market size and forecast, by indication
7.4.5.3.3.India market size and forecast, by distribution channel

7.4.5.4.Australia

7.4.5.4.1.Australia market size and forecast, by product
7.4.5.4.2.Australia market size and forecast, by indication
7.4.5.4.3.Australia market size and forecast, by distribution channel

7.4.5.5.Rest of Asia-Pacific

7.4.5.5.1.Rest of Asia-Pacific market size and forecast, by product
7.4.5.5.2.Rest of Asia-Pacific market size and forecast, by indication
7.4.5.5.3.Rest of Asia-Pacific market size and forecast, by distribution channel

7.5.LAMEA

7.5.1.Key market trends and opportunities
7.5.2.LAMEA market size and forecast, by country
7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by indication
7.5.5.LAMEA market size and forecast, by distribution channel

7.5.5.1.Brazil

7.5.5.1.1.Brazil market size and forecast, by product
7.5.5.1.2.Brazil market size and forecast, by indication
7.5.5.1.3.Brazil market size and forecast, by distribution channel

7.5.5.2.Argentina

7.5.5.2.1.Argentina market size and forecast, by product
7.5.5.2.2.Argentina market size and forecast, by indication
7.5.5.2.3.Argentina market size and forecast, by distribution channel

7.5.5.3.Saudi Arabia

7.5.5.3.1.Saudi Arabia market size and forecast, by product
7.5.5.3.2.Saudi Arabia market size and forecast, by indication
7.5.5.3.3.Saudi Arabia market size and forecast, by distribution channel

7.5.5.4.Colombia

7.5.5.4.1.Colombia market size and forecast, by product
7.5.5.4.2.Colombia market size and forecast, by indication
7.5.5.4.3.Colombia market size and forecast, by distribution channel

7.5.5.5.Turkey

7.5.5.5.1.Turkey market size and forecast, by product
7.5.5.5.2.Turkey market size and forecast, by indication
7.5.5.5.3.Turkey market size and forecast, by distribution channel

7.5.5.6.Rest of LAMEA

7.5.5.6.1.Rest of LAMEA market size and forecast, by product
7.5.5.6.2.Rest of LAMEA market size and forecast, by indication
7.5.5.6.3.Rest of LAMEA market size and forecast, by distribution channel

CHAPTER 8:COMPANY PROFILES

8.1.Aerogen, Inc.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Product portfolio

8.2.AstraZeneca PLC

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.Baxter International Inc.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product Portfolio
8.3.5.Business performance

8.4.Boehringer Ingelheim International GmbH

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance

8.5.3M COMPANY

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments

8.6.GF Health Products, Inc.

8.6.1.Company overview
8.6.2.Product portfolio

8.7.GlaxoSmithKline Plc

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.Koninklijke Philips N.V. (Philips)

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.Novartis AG

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.PARI medical Holding GMBH

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments

8.11.Smith's Group Plc

8.11.1.Company overview
8.11.2.Company snapshot
8.11.3.Operating business segments
8.11.4.Product portfolio
8.11.5.Business performance